AGIO Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.

$48.82  +1.49 (3.14%)
As of 03/05/2021 15:59:34 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
USA
USA
07/24/2013
69,601,332
764,896
$3,402,809,121
0.00%
SEC Edgar Online
10-Q
10-K
00847X104
US00847X1046
BCBVTX1

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-10.39
8.48
16.75
-81.94%
-161.11%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy